SMS Reminder to Assess Adherence

Boehringer Ingelheim

Status: Completed

Conditions: Pulmonary Disease, Chronic Obstructive

Treatments: Procedure: control group; Procedure: SMS reminder

Study type: Observational

Funder types: Industry

Identifiers

NCT01308476

205.474

Details and patient eligibility

About

6 months open label non-interventional observational study acc to § 4, section 23 and § 67, section 6 German Medicines Act with two parallel groups

1. the SMS group receiving a daily SMS - a reminder to inhale Spiriva® 18 Microgram
2. the control group not receiving a daily SMS reminder

Full description

Purpose:

Study Design:

observational

Enrollment: 95 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Chronic obstructive pulmonary disease (COPD) patients requiring long-acting bronchodilators according to approved Summary of Product Characteristics (SPC) and guidelines
• User of mobile phone

Exclusion criteria

• Patients presenting with the general and specific contraindications listed in the Patient Information Leaflet and the SPC

Trial design

95 participants in 2 patient groups

SMS group

Treatment:

Procedure: SMS reminder

control group

Treatment:

Procedure: control group